Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs).

Mathian A. et al, (2023), Joint Bone Spine, 91

A cellular overview of immunometabolism in systemic lupus erythematosus

Psarras A. and Clarke A., (2023), Oxford Open Immunology, 4

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.

Md Yusof MY. et al, (2023), Rheumatol Adv Pract, 7

Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.

Psarras A. and Vital EM., (2022), N Engl J Med, 387, 1528 - 1529

Emerging concepts of type I interferons in SLE pathogenesis and therapy

Psarras A. et al, (2022), Nature Reviews Rheumatology

Keratinocytes: From passive targets to active mediators of systemic autoimmunity

Psarras A. and Vital EM., (2022), Science Translational Medicine, 14

Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus

Carter LM. et al, (2022), Arthritis and Rheumatology

TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation.

Psarras A. et al, (2021), J Immunol, 206, 785 - 796

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.

Psarras A. et al, (2020), Nat Commun, 11

B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus

El‐Sherbiny YM. et al, (2020), Arthritis & Rheumatology, 72, 769 - 779

A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features

El-Sherbiny YM. et al, (2018), Scientific Reports, 8

Erratum to: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features (Scientific Reports, (2018), 8, 1, (5793), 10.1038/s41598-018-24198-1)

El-Sherbiny YM. et al, (2018), Scientific Reports, 8

Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status

Md Yusof MY. et al, (2018), Annals of the Rheumatic Diseases, 77, 1432 - 1439

TNF-alpha Regulates Plasmacytoid Dendritic Cells By Suppressing IFN-alpha Production and Enhancing Th1 and Th17 Cell Differentiation

Psarras A. et al, (2018), ARTHRITIS & RHEUMATOLOGY, 70

Type I IFN Production Is Induced By Non-Haematopoietic Tissue Cells but Not Plasmacytoid Dendritic Cells in Preclinical Autoimmunity and SLE

Psarras A. et al, (2018), ARTHRITIS & RHEUMATOLOGY, 70

Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy

Psarras A. et al, (2017), Rheumatology, kew431 - kew431

A critical view on cardiovascular risk in systemic sclerosis.

Psarras A. et al, (2017), Rheumatol Int, 37, 85 - 95

Giant cell arteritis and systemic sclerosis: a rare overlap syndrome

Psarras A. et al, (2014), Rheumatology Reports, 6

Systemic sclerosis and silicone breast implant: a case report and review of the literature.

Psarras A. et al, (2014), Case Rep Rheumatol, 2014

Include forthcoming?